Advertisement

Brexit, “No Deal” concerns for pharmaceuticals

Brexit, “No Deal” concerns for pharmaceuticals “Now in our planning the Government has given us guidance that in preparing stockpiles of medicine we should assume six weeks for the delays that may be at the border. If that number is wrong then that would cause serious consequences for us if we have and therefore got the planning wrong.”

Mike Thompson, Chief Executive, Association of the British Pharmaceutical Industry speaking of the biggest concerns for pharmaceuticals.

In October 2018 the Exiting the European Union Committee held a session focusing on no deal and contingency planning being undertaken by businesses large and small.

Link to full session from the ongoing inquiry “The progress of the UK’s negotiations on EU withdrawal” held on 10 October 2018

This video was first published on Facebook 11 October 2018

pharmaceuticals

Post a Comment

0 Comments